NCT00140244
- Conditions
- Dyslipidemias, Glucose Metabolism Disorders, HAART-induced Lipodystrophy and Metabolic Syndrome, +11 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Hyperinsulinism. Study availability and eligibility vary by location and protocol.
NCT00140244
NCT00802204
NCT01559857
NCT01080989
NCT03141827
NCT02499107
NCT03142503
Not specified
NCT02216552
NCT00864461